12 Nov 2014 - Actavis in talks to buy Allergan for at least $60 billion: Bloomberg | | | | | | | Monday to Friday 8am - 6pm Saturday 9am - 6pm | | Investment Pulse | | 12 Nov 2014 | | The indices on the global map above are refreshed with market data each time you open your email. Feeds are taken from our News and Views hub. | | | | | MARKETWATCH – LAST UPDATE: Nov 12, 2014 15:02 | By Carla Mozee, MarketWatch Pound slides after dovish BOE inflation report. LONDON-- U.K. stocks fell on Wednesday, with banking stocks lower after paying fines over allegations of attempted rigging of the foreign-exchange market. The FTSE 100 lost 0.4%... |
|
| | | MARKETWATCH – LAST UPDATE: Nov 12, 2014 15:02 | |
|
| | | MARKETWATCH – LAST UPDATE: Nov 12, 2014 12:32 | |
|
| | | | | | | | | The Bank of England has put an end to any hopes that interest rates will rise soon | | | | | | | | | - Actavis Plc (ACT.NaE) is in talks to buy Allergan Inc (AGN.NaE) for at least $60 billion in a deal that could culminate this month, Bloomberg reported, citing sources familiar with the matter. The two companies are trying to narrow a gap of about $3... |
|
|
- Citigroup Inc (C.NaE) said it will pay $1.02 billion to settle a probe by regulators for failing to stop traders from trying to manipulate the foreign exchange market. "Citi acted quickly upon becoming aware of issues in our foreign exchange business... |
|
|
A U.S. bank regulator on Wednesday fined three top banks a total of $950 million for failing to prevent employees' misconduct in foreign exchange trading. The Office of the Comptroller of the Currency said Bank of America Corp (BAC.NaE) agreed to pay $250... |
|
| | | | | | | | | | | Global stocks were mixed in muted trading. The Nikkei rallied on domestic news. United States US shares managed to...
| | | | | | | | | Whilst we compile these hyperlinks and send them to you because we think they may be relevant and of interest, these hyperlinks may direct you to websites or resources owned and operated by third parties. These third party websites or resources have their own terms of use and we urge you to review them. We do not accept any responsibility or liability relating to any third party websites or resources, and your access and use of such services and content is at your own risk. The information transmitted is intended for the person or entity to which it is addressed and may contain confidential, privileged or copyrighted material. If you receive this in error, please contact the sender and delete the material from any computer. Fidelity only gives information on products and services and does not give investment advice to retail clients based on individual circumstances. Any comments or statements made are not necessarily those of Fidelity. All e-mails may be monitored. FIL Investments International (Reg. No.1448245), FIL Investment Services (UK) Limited (Reg. No. 2016555), FIL Pensions Management (Reg. No. 2015142) and Financial Administration Services Limited (Reg. No. 1629709) are authorised and regulated in the UK by the Financial Conduct Authority. FIL Life Insurance Limited (Reg No. 3406905) is authorised in the UK by the Prudential Regulation Authority and regulated in the UK by the Financial Conduct Authority and the Prudential Regulation Authority. Registered offices at Oakhill House, 130 Tonbridge Road, Hildenborough, Tonbridge, Kent TN11 9DZ. PSSO0067/0614 To guarantee delivery of this email please add alerts@news.fidelity.co.uk to your address book and safe senders list. Unsubscribe from all Fidelity marketing emails. | | | | |
0 comments:
Post a Comment